TCL Archive Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study December 26, 2014
TCL Archive Clinical Trials: “Master Protocol” To Rely On Biomarkers In Testing Multiple Lung Cancer Agents November 15, 2013
TCL Archive WHI Investigators Reiterate: Breast Cancer, CHD Risks Too Great For Routine HT Use November 2, 2002
TCL Archive CMS Develops New Math of Medicare: Reimbursement Money for Outcomes Data. February 4, 2005